Aerosols

Scone Medical Solutions Inc Announces Issuance of U.S. Patent for Self-Contained Negative Pressure Environment

Retrieved on: 
Wednesday, April 28, 2021

Patent 10,967,204 is directed toward the use of negative pressure in a small-capacity barrier protection device that actively removes airborne particulates emitted around a patient\'s upper torso.

Key Points: 
  • Patent 10,967,204 is directed toward the use of negative pressure in a small-capacity barrier protection device that actively removes airborne particulates emitted around a patient\'s upper torso.
  • The Self-Contained Negative Pressure Environment (SCONE) prevents exposure to pathogenic airborne particulates during triage and transportation, and treatments, including aerosol-generating procedures (AGPs) and end-of-life care.
  • The SCONE system is a collapsible device with a flexible cover with arm access holes for medical professionals to reach in and treat patients by performing various procedures.
  • The SCONE device was Authorized for Emergency Use by the FDA on December 18, 2020 and is in the process of applying for full FDA approval.\n"We are extremely pleased to receive a newly-issued Patent for our Self-Contained Negative Pressure Environment (SCONE) device.

Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease

Retrieved on: 
Tuesday, April 27, 2021

Ensifentrine also activates the Cystic Fibrosis Transmembrane Conductance Regulator (\xe2\x80\x9cCFTR\xe2\x80\x9d), which is beneficial in reducing mucous viscosity and improving mucociliary clearance.

Key Points: 
  • Ensifentrine also activates the Cystic Fibrosis Transmembrane Conductance Regulator (\xe2\x80\x9cCFTR\xe2\x80\x9d), which is beneficial in reducing mucous viscosity and improving mucociliary clearance.
  • The Company is evaluating nebulized ensifentrine in its Phase 3 clinical program ENHANCE (\xe2\x80\x9cEnsifentrine as a Novel inHAled Nebulized COPD thErapy\xe2\x80\x9d) for COPD maintenance treatment.
  • Two additional formulations of ensifentrine are in Phase 2 development for the treatment of COPD: dry powder inhaler (\xe2\x80\x9cDPI\xe2\x80\x9d) and pressurized metered-dose inhaler (\xe2\x80\x9cpMDI\xe2\x80\x9d).
  • These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.\n"

Worldwide Portable Compressor Nebulizer Industry to 2025 - Increasing Demand for Home Healthcare Devices Presents Opportunities

Retrieved on: 
Tuesday, April 20, 2021

In Nov 2018, Koninklijke Philips launched InnoSpire Go portable nebulizer in the U.S.

Key Points: 
  • In Nov 2018, Koninklijke Philips launched InnoSpire Go portable nebulizer in the U.S.
  • The product is the smallest and lightest portable handheld nebulizer.\n2.
  • In October 2018, Pari Pharma gets approval for its e-FLOW technology device LAMIRA, which is the only nebulizer system to deliver amikacin liposome inhalation suspension (ARIKAYCE).
  • The projections are calculated using proven research methodologies.\nThe report has been compiled through extensive primary and secondary research.

Outlook on the Digital Respiratory Devices Global Market to 2030 - Focus on Sensors, Smart Inhalers & Nebulizers, Application, Countries and Competitive Landscape

Retrieved on: 
Monday, April 19, 2021

b"The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030.

Key Points: 
  • b"The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030.
  • The study also provides exhaustive information on competitive landscape, brand share landscape, market share of the leading players, as well as other vital information with respect to the global digital respiratory devices market.
  • The report considers sensors and apps, and smart inhalers and nebulizers.\nSome of the key players contributing to the Global Digital Respiratory Devices Market include 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp.
  • z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.\nHow pharmaceutical companies are capitalizing on the opportunity for connected inhalers to improve drug sales?\nWhat has been the impact of the COVID-19 pandemic on global digital respiratory devices market?\nWhat are the potential recovery scenarios of the market from the COVID-19 pandemic, and how can it impact the market forecast?\nHow will the pharma industry evolve in terms of drug-based devices in the future?\nWhat are the potential business models in global digital respiratory devices market?\nWhat are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?\nWhat are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?\nWhat was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2021?\nHow is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2030?\nWhat are the influencing factors that may affect the market share of the key players?\nWhat is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?\nHow can market intelligence on digital respiratory device add value to an organization's decision-making process?\n"

AllergyGuard™: A Possible Solution to Seasonal Allergies

Retrieved on: 
Thursday, April 8, 2021

This screening material is revolutionary in that it provides filtering capabilities, reduces pollen, pollution, fly ash and even filters some bacteria and viruses.

Key Points: 
  • This screening material is revolutionary in that it provides filtering capabilities, reduces pollen, pollution, fly ash and even filters some bacteria and viruses.
  • Homeowners and business owners alike will be able to improve indoor air quality while helping to keep allergies at bay with this innovative traditional screen mesh alternative.
  • AllergyGuard is a high-performance, nano-fiber, three-layer screen mesh that was engineered and tested to filter out ultra-fine dust PM 2.5 and fine dust PM 10.
  • It can filter out particles that are only 300 nanometers, compared to traditional window screen mesh that can only keep out large particles measuring 2,000,000 nanometers.

OMRON Healthcare, Asthma and Allergy Foundation of America (AAFA) Join Together to Provide More Respiratory Medical Care to Underserved Communities

Retrieved on: 
Wednesday, March 31, 2021

OMRON's support will also help AAFA deliver educational information to communities most in need of more resources.

Key Points: 
  • OMRON's support will also help AAFA deliver educational information to communities most in need of more resources.
  • Respiratory care products like nebulizers play a critical role in asthma management," said OMRON Healthcare president and CEO, Ranndy Kellogg.
  • Black, Hispanic, Indigenous Americans and other minority groups face the highest burden of asthma because of the impact of health disparities3.
  • OMRON's donated nebulizers will reach underserved communities nationwide and expand access to asthma management technology.

Replaceable PM 2.5 Carbon Filters Now Available for The Maskie Filtered

Retrieved on: 
Thursday, March 25, 2021

UNION, N.J., March 25, 2021 /PRNewswire-PRWeb/ --To reaffirm their commitment to the health and safety of all wearers, The Maskie Filtered now features replaceable PM 2.5 Carbon Filters that can easily be swapped in and out of all Filtered Maskies.

Key Points: 
  • UNION, N.J., March 25, 2021 /PRNewswire-PRWeb/ --To reaffirm their commitment to the health and safety of all wearers, The Maskie Filtered now features replaceable PM 2.5 Carbon Filters that can easily be swapped in and out of all Filtered Maskies.
  • Launched last year, The Maskie Filtered is a hybrid scrunchie and fabric face mask that is easily adjustable and configured for various uses.
  • These carbon filters help prevent you from breathing in any PM 2.5, which is particulate matter that is 2.5 micrometers or smaller.
  • These PM 2.5 carbon filters are easily replaced within all Maskie Filtered units without the need to cut the garment at all to keep it flexible and durable.

Worldwide Portable Compressor Nebulizer Industry to 2025 - Increasing Demand for Home Healthcare Devices Presents Opportunities

Retrieved on: 
Tuesday, March 23, 2021

This research report categorizes the Portable Compressor Nebulizer to forecast the revenues and analyze the trends in each of the following sub-markets:

Key Points: 
  • This research report categorizes the Portable Compressor Nebulizer to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Type, the Portable Compressor Nebulizer Market is examined across Mesh Nebulizer, Pneumatic Nebulizer, and Ultrasonic Nebulizer.
  • Based on Geography, the Portable Compressor Nebulizer Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa.
  • What are the technology trends and regulatory frameworks in the Global Portable Compressor Nebulizer Market?
  • What are the modes and strategic moves considered suitable for entering the Global Portable Compressor Nebulizer Market?

Global Portable Compressor Nebulizer Market Research Report (2020 to 2025) - by Type, Distribution Channel and Application - ResearchAndMarkets.com

Retrieved on: 
Friday, March 19, 2021

What is the market size and forecast of the Global Portable Compressor Nebulizer Market?

Key Points: 
  • What is the market size and forecast of the Global Portable Compressor Nebulizer Market?
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Portable Compressor Nebulizer Market during the forecast period?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Portable Compressor Nebulizer Market?
  • What are the modes and strategic moves considered suitable for entering the Global Portable Compressor Nebulizer Market?

InventHelp Inventors Develop Effective Tool for Collecting Dust (POO-555)

Retrieved on: 
Wednesday, March 17, 2021

The invention provides an effective way to collect and clean dust and particles.

Key Points: 
  • The invention provides an effective way to collect and clean dust and particles.
  • In doing so, it offers an improved alternative to traditional contractor push brooms.
  • As a result, it eliminates the need to inhale fine particulates and it enhances safety and efficiency.
  • The original design was submitted to the Portland sales office of InventHelp.